Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome: a Multicenter, Randomized, Double-blind, Placebo Controlled Clinical Trial

NCT03457324 is registered in ClinicalTrials.gov with ZhaoXiang Bian as lead sponsor.

NCT NCT03457324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03457324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome: a Multicenter, Randomized, Double-blind, Placebo Controlled Clinical Trial
Lead sponsor
ZhaoXiang Bian
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 8, 2018
Completion date
June 30, 2021
Enrollment
392 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome